Yannis Lassoued
Research Subjects
Research Interests
Yannis Lassoued has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Andreas Werner
Association Clinique et Thérapeutique Infantile du Val-de-Marne France (ACTIV) , Créteil
1 shared publicationAndré Birgy
Inserm, IAME UMR 1137, Université Paris Cité and Université Sorbonne Paris Nord , Paris
1 shared publicationBruno Franji
Centre Hospitalier Intercommunal de Créteil, Clinical Research Centre, Université Paris Est, IMRB-GRC GEMINI , Créteil
1 shared publicationChristophe Batard
Association Clinique et Thérapeutique Infantile du Val-de-Marne France (ACTIV) , Créteil
1 shared publication- Corinne Levy
ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France
1 shared publication Fabienne Cahn Sellem
Association Clinique et Thérapeutique Infantile du Val-de-Marne France (ACTIV) , Créteil
1 shared publication
Latest Publications
- 9 October 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Impact of RSV Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis
Background: Acute otitis media (AOM) is the leading cause of antibiotic prescription in children. Respiratory syncytial virus (RSV) is suspected to play an important role in AOM. The aim of this study was to estimate the impact of RSV immunization on the rate of subsequent AOM in children, as this effect remains unknown. Methods: We conducted an interrupted time-series analysis based on a French network involving 110 ambulatory pediatricians, trained in pediatric infectious diseases (PARI network). All ambulatory visits for AOM, from June 2017 to February 2025 were included. The main outcome was the monthly rate of pediatric ambulatory visits for AOM in infants aged < 12 months per 1000 pediatric ambulatory visits over time, assessed by a seasonally adjusted quasi-Poisson regression model. Bronchiolitis and urinary tract infections (UTI) were analyzed over the same period, as positive and negative controls, respectively. Results: We included 70 452 cases of AOM, 13 284 bronchiolitis and 814 UTI. The rate of AOM per 1000 visits in infants aged < 12 months significantly decreased after RSV immunization implementation (−23.7%, 95% CI −37.6 to −9.7, P = .0014), whereas no significant change was observed in older age groups. We observed similar trends for bronchiolitis. The monthly rate of UTI did not significantly decrease. Conclusions: RSV immunization led to a strong reduction of AOM rate in infants aged < 12 months. Beyond its efficacy in preventing RSV-related lower respiratory infections in infants aged < 12 months, RSV immunization may contribute to reduce the burden of AOM in children.
- 9 October 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Impact of RSV Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis
Background: Acute otitis media (AOM) is the leading cause of antibiotic prescription in children. Respiratory syncytial virus (RSV) is suspected to play an important role in AOM. The aim of this study was to estimate the impact of RSV immunization on the rate of subsequent AOM in children, as this effect remains unknown. Methods: We conducted an interrupted time-series analysis based on a French network involving 110 ambulatory pediatricians, trained in pediatric infectious diseases (PARI network). All ambulatory visits for AOM, from June 2017 to February 2025 were included. The main outcome was the monthly rate of pediatric ambulatory visits for AOM in infants aged < 12 months per 1000 pediatric ambulatory visits over time, assessed by a seasonally adjusted quasi-Poisson regression model. Bronchiolitis and urinary tract infections (UTI) were analyzed over the same period, as positive and negative controls, respectively. Results: We included 70 452 cases of AOM, 13 284 bronchiolitis and 814 UTI. The rate of AOM per 1000 visits in infants aged < 12 months significantly decreased after RSV immunization implementation (−23.7%, 95% CI −37.6 to −9.7, P = .0014), whereas no significant change was observed in older age groups. We observed similar trends for bronchiolitis. The monthly rate of UTI did not significantly decrease. Conclusions: RSV immunization led to a strong reduction of AOM rate in infants aged < 12 months. Beyond its efficacy in preventing RSV-related lower respiratory infections in infants aged < 12 months, RSV immunization may contribute to reduce the burden of AOM in children.